Literature DB >> 22450675

The specialized roles of immature and mature dendritic cells in antigen cross-presentation.

Richard A Hopkins1, John E Connolly.   

Abstract

Exogenous antigen cross-presentation is integral to the stimulation of cytotoxic T-lymphocytes against viruses and tumors. Central to this process are dendritic cells (DCs), which specialize in cross-presentation. DCs may be considered to exist in two radically different states of activation, generally referred to as immature and mature. In each of these states, the cell has a series of separate and specialized abilities for the induction of T-cell immunity. In the immature state, the DC is adept in surveying the periphery, acquiring and storing antigen, but has a limited capacity for direct T-cell activation. During a brief and defined window of time following DC stimulation, nearly every aspect of antigen handling changes, as it transitions from an entity focused on protein preservation to one capable of efficient cross-presentation. It is this time period and the underlying molecular mechanisms active here, which form the core of our studies on cross-presentation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22450675     DOI: 10.1007/s12026-012-8300-z

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  180 in total

Review 1.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

Review 2.  Pattern recognition receptors: doubling up for the innate immune response.

Authors:  Siamon Gordon
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

3.  Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I.

Authors:  Tiziana Di Pucchio; Bithi Chatterjee; Anna Smed-Sörensen; Sandra Clayton; Adam Palazzo; Monica Montes; Yaming Xue; Ira Mellman; Jacques Banchereau; John E Connolly
Journal:  Nat Immunol       Date:  2008-03-30       Impact factor: 25.606

4.  Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells.

Authors:  Kristi Baker; Shuo-Wang Qiao; Timothy T Kuo; Victoria G Aveson; Barbara Platzer; Jan-Terje Andersen; Inger Sandlie; Zhangguo Chen; Colin de Haar; Wayne I Lencer; Edda Fiebiger; Richard S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

5.  Mannose receptor polyubiquitination regulates endosomal recruitment of p97 and cytosolic antigen translocation for cross-presentation.

Authors:  Matthias Zehner; Achmet Imam Chasan; Verena Schuette; Maria Embgenbroich; Thomas Quast; Waldemar Kolanus; Sven Burgdorf
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

Review 6.  C-type lectins and phagocytosis.

Authors:  Ann M Kerrigan; Gordon D Brown
Journal:  Immunobiology       Date:  2009-03-03       Impact factor: 3.144

7.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta.

Authors:  Jonathan C Kagan; Tian Su; Tiffany Horng; Amy Chow; Shizuo Akira; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2008-02-24       Impact factor: 25.606

8.  Priming of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cell responses by dendritic cells loaded with HIV-1 proteins.

Authors:  Xiao-Li Huang; Zheng Fan; Lian Zheng; Luann Borowski; Hongyi Li; Elaine K Thomas; William H Hildebrand; Xiao-Qing Zhao; Charles R Rinaldo
Journal:  J Infect Dis       Date:  2002-12-19       Impact factor: 5.226

Review 9.  The coordination of signaling during Fc receptor-mediated phagocytosis.

Authors:  Joel A Swanson; Adam D Hoppe
Journal:  J Leukoc Biol       Date:  2004-10-05       Impact factor: 4.962

10.  Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.

Authors:  M J Bevan
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  7 in total

1.  Clitocybe nuda Activates Dendritic Cells and Acts as a DNA Vaccine Adjuvant.

Authors:  Mei-Hsing Chen; Wei-Sung Li; Yun-Sheng Lue; Ching-Liang Chu; I-Hong Pan; Ching-Huai Ko; Der-Yuan Chen; Ching-Hsiung Lin; Sheng-Hao Lin; Chih-Peng Chang; Chi-Chen Lin
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-22       Impact factor: 2.629

2.  Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide.

Authors:  Yohei Takeda; Masahiro Azuma; Kenji Funami; Hiroaki Shime; Misako Matsumoto; Tsukasa Seya
Journal:  Front Immunol       Date:  2018-03-14       Impact factor: 7.561

3.  Tropomodulin1 Expression Increases Upon Maturation in Dendritic Cells and Promotes Their Maturation and Immune Functions.

Authors:  Xianmei Liu; Xue Xia; Xifu Wang; Jing Zhou; Lanping Amy Sung; Jinhua Long; Xueyu Geng; Zhu Zeng; Weijuan Yao
Journal:  Front Immunol       Date:  2021-01-15       Impact factor: 7.561

4.  Withaferin A inhibits lymphocyte proliferation, dendritic cell maturation in vitro and prolongs islet allograft survival.

Authors:  Kenjiro Kumano; Mazhar A Kanak; Prathab Balaji Saravanan; J P Blanck; Yang Liu; Srividya Vasu; Michael Lawrence; Bashoo Naziruddin
Journal:  Sci Rep       Date:  2021-05-21       Impact factor: 4.996

5.  Identification of Profound Metabolic Alterations in Human Dendritic Cells by Progesterone Through Integrated Bioinformatics Analysis.

Authors:  Sainan Zhang; Su Liu; Ling Hong; Xiaohui Wang; Lianghui Diao; Songchen Cai; Tailang Yin; Yong Zeng
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

Review 6.  Dendritic cell apoptosis and the pathogenesis of dengue.

Authors:  Sharon de T Martins; Guilherme F Silveira; Lysangela R Alves; Claudia Nunes Duarte dos Santos; Juliano Bordignon
Journal:  Viruses       Date:  2012-11-01       Impact factor: 5.048

7.  Geldanamycin-mediated inhibition of heat shock protein 90 partially activates dendritic cells, but interferes with their full maturation, accompanied by impaired upregulation of RelB.

Authors:  Stefanie Trojandt; Angelika B Reske-Kunz; Matthias Bros
Journal:  J Exp Clin Cancer Res       Date:  2014-02-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.